Myths and realities of antiemetic treatment.

This publication has 21 references indexed in Scilit:

• Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model
  Cancer, 1989
• Laparotomic eventration or colonic prolapse after chemotherapy‐induced emesis
  Journal of Surgical Oncology, 1988
• EVALUATION OF AN ANTIEMETIC REGIMEN WITH HIGH-DOSAGE METHOCHLOPRAMIDE, DEXAMETHASONE AND DIPHENHYDRAMINE IN PATIENTS ON CHEMOTHERAPY WITH CISPLATINUM
  1986
• Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.
  Journal of Clinical Oncology, 1985
• A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
  Journal of Clinical Oncology, 1985
• High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.
  1982
• THE COURSE OF NAUSEA AND VOMITING AFTER HIGH-DOSE CYCLOPHOSPHAMIDE
  1982
• A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotherapy with cis-platinum
  Gynecologic Oncology, 1980
• THERAPY-LINKED LEUKÆMIA
  The Lancet, 1977
• Cancer Treatment Needs Better Antiemetics
  New England Journal of Medicine, 1975